Home›Companies›Biotech & Pharma›Commense Bio

Commense Bio, Inc.

Develops engineered bacterial treatments for patients with invasive infections.

Updated Nov 10, 2026·Latest SEC filing Jun 12, 2026·Suggest an edit

About Commense Bio

Commense Bio is a private company based in Boulder, Colorado. It has reported $2,470,334 raised in one offering on Form D since June 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 18, 2026Jun 12, 2026$2,470,334of $2.6M target31$79,688Equity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Commense Bio's Form D filed Jun 12, 2026.

Sources

  1. SECCommense Bio, Inc. filing history
  2. CompanyCommense Bio team